Veeva Systems (NYSE: VEEV) – Impenetrable Wide Regulatory Moat
Veeva built a wide regulatory moat around its life sciences-focused software business, helping pharmaceutical companies manage mission-critical functions across the entire product lifecycle. These functions include highly-regulated drug safety reporting required by global health authorities. Safety reporting is so important to pharmaceutical companies that failure to do so can potentially lead to drugs being removed from shelves. Such mission-critical compliance requirements explain why 14 of the top 20 pharma companies are committed to using Veeva’s latest…
